April 2009
Volume 50, Issue 13
ARVO Annual Meeting Abstract  |   April 2009
Secondary Hyalinosis/Amyloidosis in Macular Corneal Dystrophy
Author Affiliations & Notes
  • S. H. Chang
    Washington University School of Medicine, St. Louis, Missouri
  • D. A. Patel
    Washington University School of Medicine, St. Louis, Missouri
  • G. J. Harocopos
    Pathology and Immunology,
    Washington University School of Medicine, St. Louis, Missouri
  • D. H. Thang
    Eye Hospital of Ho Chi Minh City, Ho Chi Minh City, Viet Nam
  • A. J. W. Huang
    Washington University School of Medicine, St. Louis, Missouri
  • Footnotes
    Commercial Relationships  S.H. Chang, None; D.A. Patel, None; G.J. Harocopos, None; D.H. Thang, None; A.J.W. Huang, None.
  • Footnotes
    Support  NIH EY017609, NRSA 5-T32-EY13360-09, RPB
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 4313. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. H. Chang, D. A. Patel, G. J. Harocopos, D. H. Thang, A. J. W. Huang; Secondary Hyalinosis/Amyloidosis in Macular Corneal Dystrophy. Invest. Ophthalmol. Vis. Sci. 2009;50(13):4313.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To report a previously unreported finding of sub-epithelial amyloid deposits of transforming growth factor ß-induced protein (TGFBI) and hyaline deposits in macular corneal dystrophy (MCD).

Methods: : Routine histopathological staining with alcian blue, Congo red and Masson trichrome were carried out on corneal sections of three unrelated cases of MCD. Non-dystrophic corneal sections were used as controls. Tissue sections were also stained with a commercial TGFBI antibody and 200 µM Thioflavin-T (ThT), a fluorescent stain for amyloid protein. Immunofluorescence sections were imaged using laser confocal microscopy.

Results: : All three cases of MCD showed alcian blue positive deposits throughout the stroma, which did not stain with Congo red, Masson trichrome, and ThT. Tissue sections from one Asian male with MCD showed prominent sub-epithelial deposits that stained positively with Alcian blue and Masson trichrome. Of significance, some of these sub-epithelial deposits also stained with TGFBI antibody. Furthermore, these TGFBI-positive deposits in the cornea also partially stained positively with ThT, indicative of the presence of amyloid aggregates. Genotyping of this index case did not reveal any mutations in the TGFBI gene. As expected, non-dystrophic corneal tissues did not show discernible TGFBI aggregates by immunostaining.

Conclusions: : Consistent with previous reports, there is no known association between TGFBI gene mutation and MCD. However, one of our cases showed sub-epithelial deposits containing TGFBI. Deposits in this case were found to be partially amyloidogenic by ThT staining. These findings suggest that secondary hyalinosis/amyloidosis caused by non-mutant or wild-type TGFBI can occur in MCD, similar to secondary amyloidosis observed in keratoconus, Fuchs’ endothelial dystrophy, or other corneal inflammatory conditions.

Keywords: degenerations/dystrophies • pathology: human • microscopy: light/fluorescence/immunohistochemistry 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.